List of Tables
    Table 1. NSAIDs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. NSAIDs Market Trends
    Table 3. NSAIDs Market Drivers
    Table 4. NSAIDs Market Challenges
    Table 5. NSAIDs Market Restraints
    Table 6. Global NSAIDs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States NSAIDs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global NSAIDs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States NSAIDs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top NSAIDs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global NSAIDs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global NSAIDs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global NSAIDs Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global NSAIDs Sales Share by Manufacturer, 2017-2022
    Table 15. Global NSAIDs Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global NSAIDs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global NSAIDs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs as of 2021)
    Table 18. Top Players of NSAIDs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers NSAIDs Product Type
    Table 20. Date of International Manufacturers Enter into NSAIDs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top NSAIDs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States NSAIDs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States NSAIDs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States NSAIDs Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States NSAIDs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global NSAIDs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global NSAIDs Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global NSAIDs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global NSAIDs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global NSAIDs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America NSAIDs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America NSAIDs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific NSAIDs Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific NSAIDs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe NSAIDs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe NSAIDs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America NSAIDs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa NSAIDs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa NSAIDs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa NSAIDs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bayer Corporation Information
    Table 43. Bayer Description and Business Overview
    Table 44. Bayer NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Bayer NSAIDs Product
    Table 46. Bayer Recent Development
    Table 47. Novacap Corporation Information
    Table 48. Novacap Description and Business Overview
    Table 49. Novacap NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Novacap Product
    Table 51. Novacap Recent Development
    Table 52. Abbott Corporation Information
    Table 53. Abbott Description and Business Overview
    Table 54. Abbott NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Abbott Product
    Table 56. Abbott Recent Development
    Table 57. Pfizer Corporation Information
    Table 58. Pfizer Description and Business Overview
    Table 59. Pfizer NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Pfizer Product
    Table 61. Pfizer Recent Development
    Table 62. Johnson & Johnson Corporation Information
    Table 63. Johnson & Johnson Description and Business Overview
    Table 64. Johnson & Johnson NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Johnson & Johnson Product
    Table 66. Johnson & Johnson Recent Development
    Table 67. Cigna Corporation Information
    Table 68. Cigna Description and Business Overview
    Table 69. Cigna NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Cigna Product
    Table 71. Cigna Recent Development
    Table 72. Geri-Care Pharmaceuticals Corporation Information
    Table 73. Geri-Care Pharmaceuticals Description and Business Overview
    Table 74. Geri-Care Pharmaceuticals NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Geri-Care Pharmaceuticals Product
    Table 76. Geri-Care Pharmaceuticals Recent Development
    Table 77. Perrigo Company Corporation Information
    Table 78. Perrigo Company Description and Business Overview
    Table 79. Perrigo Company NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Perrigo Company Product
    Table 81. Perrigo Company Recent Development
    Table 82. Kopran Corporation Information
    Table 83. Kopran Description and Business Overview
    Table 84. Kopran NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Kopran Product
    Table 86. Kopran Recent Development
    Table 87. Merck Sharp & Dohme Corporation Information
    Table 88. Merck Sharp & Dohme Description and Business Overview
    Table 89. Merck Sharp & Dohme NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Merck Sharp & Dohme Product
    Table 91. Merck Sharp & Dohme Recent Development
    Table 92. Sun Pharmaceutical Industries Corporation Information
    Table 93. Sun Pharmaceutical Industries Description and Business Overview
    Table 94. Sun Pharmaceutical Industries NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Sun Pharmaceutical Industries Product
    Table 96. Sun Pharmaceutical Industries Recent Development
    Table 97. GlaxoSmithKline Corporation Information
    Table 98. GlaxoSmithKline Description and Business Overview
    Table 99. GlaxoSmithKline NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. GlaxoSmithKline Product
    Table 101. GlaxoSmithKline Recent Development
    Table 102. Reddy Pharmaceuticals Corporation Information
    Table 103. Reddy Pharmaceuticals Description and Business Overview
    Table 104. Reddy Pharmaceuticals NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. Reddy Pharmaceuticals Product
    Table 106. Reddy Pharmaceuticals Recent Development
    Table 107. Verywell Corporation Information
    Table 108. Verywell Description and Business Overview
    Table 109. Verywell NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Verywell Product
    Table 111. Verywell Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. NSAIDs Customers List
    Table 115. NSAIDs Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. NSAIDs Product Picture
    Figure 2. Global NSAIDs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global NSAIDs Market Size 2017-2028 (US$ Million)
    Figure 4. Global NSAIDs Sales 2017-2028 (K Pcs)
    Figure 5. United States NSAIDs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States NSAIDs Market Size 2017-2028 (US$ Million)
    Figure 7. United States NSAIDs Sales 2017-2028 (K Pcs)
    Figure 8. United States NSAIDs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States NSAIDs Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. NSAIDs Report Years Considered
    Figure 11. Product Picture of Aspirin
    Figure 12. Product Picture of Ibuprofen
    Figure 13. Product Picture of Naproxen
    Figure 14. Product Picture of Nabumetone
    Figure 15. Product Picture of Others
    Figure 16. Global NSAIDs Market Share by Type in 2022 & 2028
    Figure 17. Global NSAIDs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global NSAIDs Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global NSAIDs Sales by Type (2017-2028) & (K Pcs)
    Figure 20. Global NSAIDs Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global NSAIDs Price by Type (2017-2028) & (USD/Pcs)
    Figure 22. United States NSAIDs Market Share by Type in 2022 & 2028
    Figure 23. United States NSAIDs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States NSAIDs Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States NSAIDs Sales by Type (2017-2028) & (K Pcs)
    Figure 26. United States NSAIDs Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States NSAIDs Price by Type (2017-2028) & (USD/Pcs)
    Figure 28. Product Picture of Back Pain Treatment
    Figure 29. Product Picture of Osteoarthritis Treatment
    Figure 30. Product Picture of Other Disease Treatment
    Figure 31. Global NSAIDs Market Share by Application in 2022 & 2028
    Figure 32. Global NSAIDs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global NSAIDs Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global NSAIDs Sales by Application (2017-2028) & (K Pcs)
    Figure 35. Global NSAIDs Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global NSAIDs Price by Application (2017-2028) & (USD/Pcs)
    Figure 37. United States NSAIDs Market Share by Application in 2022 & 2028
    Figure 38. United States NSAIDs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States NSAIDs Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States NSAIDs Sales by Application (2017-2028) & (K Pcs)
    Figure 41. United States NSAIDs Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States NSAIDs Price by Application (2017-2028) & (USD/Pcs)
    Figure 43. North America NSAIDs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 44. North America NSAIDs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe NSAIDs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 48. Europe NSAIDs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific NSAIDs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 55. Asia-Pacific NSAIDs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America NSAIDs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 67. Latin America NSAIDs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa NSAIDs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 72. Middle East & Africa NSAIDs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E NSAIDs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. NSAIDs Value Chain
    Figure 77. NSAIDs Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed